Press Release
March 12, 2018
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017
More
March 5, 2018
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2018
More
November 29, 2017
Amphastar Announces Approval for Medroxyprogesterone Acetate Injectable Suspension, USP
More
November 20, 2017
Amphastar Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference
More
November 8, 2017
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017
More
October 31, 2017
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2017
More
September 20, 2017
Amphastar Pharmaceuticals Receives FDA Approval for Sodium Bicarbonate Injection
More
August 30, 2017